✦ LIBER ✦

Report of the UK DURG regional meeting on New Horizons in Pharmacovigilance

✍ Scribed by Jo Barnes

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 62 KB
Volume: 9
Category: Article
ISSN: 1053-8569
DOI: 10.1002/1099-1557(200009/10)9:5<429::aid-pds528>3.0.co;2-9

No coin nor oath required. For personal study only.

✦ Synopsis

The UK Drug Utilization Research Group's (DURG) Regional Meeting 'New Horizons: Pharmacovigilance' was hosted by the Drug Safety Research Unit (DSRU) at Southampton on 19 May 2000. Opening the meeting, Dr Keith Beard, UK DURG chairman, welcomed delegates and speakers and thanked the DSRU team for hosting the meeting. With reference to the theme of the meeting - new horizons in pharmacovigilance - Dr Beard said that drug utilization is a very broad subject area. Introducing the first speaker Dr Saad Shakir, Director of the DSRU, Dr Beard said 'no horizon is going to be newer or more exciting than that of pharmacogenomics'. Copyright (c) 2000 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Report of the UK DURG National Meeting o

Report of the UK DURG National Meeting on 13 December 1996 held at the Royal Society of Medicine in London

📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

The theme of the meeting was `Compliance'. The morning session, chaired by Dr Hugh McGavock, Drug Utilisation Research Unit, Belfast, consisted of presentations from invited speakers on the subject of compliance. This was prompted by the imminent publication of the Royal Pharmaceutical Society Grea

‘Exploiting Adhesive Technology’ seminar

‘Exploiting Adhesive Technology’ seminar: K.W. Allen of The City University, London, UK, reports on a meeting held recently in London, UK.

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Innovations in Prescribing Information:

Innovations in Prescribing Information: Report of the UK Drug Utilisation Research Group Regional Meeting, King's Conference Centre, University of Aberdeen, Wednesday May 31, 1995

✍ Findlay Hickey 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Officer, NHS Executive, Department of Health presented an overview of prescribing indicators. He defined a prescribing indicator as 'an indicative measure, which may be relative, of the quality and/or cost of prescribing'. They could be used for three overlapping purposes: to raise awareness, target

The effects of NHS reforms on prescribin

The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group Regional Meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996

✍ Jenny Lunn 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

described a study which aimed to compare prescribing by general practices, before and after they became fundholders, with that of non-fundholders. Prescribing in 100 fundholding practices (20 ®rst wave, 31 second wave, 49 third wave) and 312 nonfundholding practices in the former Mersey Regional He

Report of the Committee on Compulsory He

Report of the Committee on Compulsory Health Insurance of the American Pharmaceutical Association**Presented and adopted in Second General Session, A. Ph. A., New York meeting, 1919.

✍ Craig, Hugh ;Mayo, C.A. ;Freericks, Frank H. ;Beal, J.H. ;Anderson, W.C. ;Mason, 📂 Article 📅 1919 🏛 Elsevier ⚖ 683 KB

Delayed and chronic effects of chemicals

Delayed and chronic effects of chemicals in the workplace: Report on a WHO meeting. EURO reports and studies 64. Regional Office for Europe, World Health Organization; Copenhagen (1982); 49 pages. Price: 4 Swiss francs

✍ Myra Karstadt 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 3 views